4-Methoxymethyl-2,3,5,6-tetrafluorobenzyl alcohol CAS 83282-91-1: Comprehensive Guide
Table of Contents
1. Product Overview & Specifications
| Parameter | Specification | Comparison with Similar Compounds |
|---|---|---|
| CAS Number | 83282-91-1 | Unique identifier vs. 87392-05-0 (non-fluorinated analog) |
| Molecular Formula | C10H10F4O2 | Higher fluorine content vs. C9H11FO2 derivatives |
| Purity Grade | ≥98% (HPLC) | Superior to industrial-grade (90-95%) alternatives |
| Storage Conditions | 2-8°C in inert atmosphere | Similar stability to fluorobenzyl derivatives |
2. Key Applications
Pharmaceutical Intermediates
Critical component in synthesis of:
- Protease inhibitors
- Fluorinated anticancer agents
- Neurological drug candidates
Advanced Material Science
• Liquid crystal precursors
• Fluoropolymer modifiers
• OLED component synthesis
3. Industry Use Cases
Case 1: Antiviral Drug Development
Used as key building block in COVID-19 therapeutic research by European pharma consortium (2022-2023):
| Parameter | Result |
|---|---|
| Reaction Yield | 82% (improved from 68% with previous compound) |
| Process Scalability | Validated at 500kg batch scale |
Case 2: Specialty Polymer Production
Enabled 15% improvement in thermal stability for aerospace coating applications through precise fluorination patterns.
4. Client Success Stories
Client A: Top 10 Global Pharma Company
Challenge: Required GMP-grade fluorinated intermediate for Phase III trial
Solution: Custom synthesis with 99.2% purity
Outcome: Accelerated regulatory approval by 6 months
Client B: Electronic Materials Manufacturer
Challenge: Develop OLED materials with enhanced electron mobility
Solution: Modified benzyl alcohol derivatives
Result: Achieved 12% efficiency improvement
5. Request Customized Solutions
Contact our technical team for:
- Bulk pricing (100kg+ quantities)
- Custom fluorination patterns
- GMP manufacturing options
Email: info@vivalr.com
Tel: (86) 15866781826
Request formulation expertise for your specific application requirements.



评论
目前还没有评论。